| Mark Grimes, MD | |
|
1025 Center St, Ashland, OH 44805-4011 | |
| (419) 289-0491 | |
| Not Available |
| Full Name | Mark Grimes |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 24 Years |
| Location | 1025 Center St, Ashland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710903646 | NPI | - | NPPES |
| 2313651 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 35-080305 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth Mansfield Hospital | Mansfield, OH | Hospital |
| Mercy Health - Tiffin Hospital | Tiffin, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-ohio Emergency Group, Llc | 7810233517 | 43 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | 4m Emergency Systems Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932152584 PECOS PAC ID: 7719882182 Enrollment ID: O20031201000099 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Emergency Professional Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093762353 PECOS PAC ID: 7214832435 Enrollment ID: O20040511000864 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Mahoning Valley Emergency Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003869652 PECOS PAC ID: 5698758993 Enrollment ID: O20040609000114 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Mves Austintown Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972555944 PECOS PAC ID: 1355308875 Enrollment ID: O20041216000550 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Mves Boardman Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205888237 PECOS PAC ID: 4688694722 Enrollment ID: O20051202000794 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Emergency Medical Services Of Lorain, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043455785 PECOS PAC ID: 1153486022 Enrollment ID: O20090210000668 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Ohio Emergency Care Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184028524 PECOS PAC ID: 1658695424 Enrollment ID: O20150127000965 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Magis Emergency Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801287511 PECOS PAC ID: 2769700392 Enrollment ID: O20150410002555 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Mid-ohio Emergency Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881164010 PECOS PAC ID: 7810233517 Enrollment ID: O20190117001823 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Entity Name | Westside Emergency Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649740879 PECOS PAC ID: 0244578938 Enrollment ID: O20190204002942 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Grimes, MD 75 Remit Dr 1056, Chicago, IL 60675-1056 Ph: (866) 916-5259 | Mark Grimes, MD 1025 Center St, Ashland, OH 44805-4011 Ph: (419) 289-0491 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
In a published report in the prestigious New England Journal of Medicine this Wednesday researchers revealed that fire fighters and rescue workers who assisted in the aftermath of the World Trade Center attacks on September 11, 2001 had compromised lung function even seven years after the incident.
New research focused on the quality of key medicines and their use as well as increasingly popular botanicals is being sponsored by the U.S. Pharmacopeial (USP) Convention under its 2009� Fellowship Program.
New findings published in Nutrition and Cancer report that consuming walnuts slowed both the development and growth of breast cancer tumors in mice.
› Verified 2 days ago
Teri L Gourley, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1025 Center St, Ashland, OH 44805 Phone: 419-289-0491 | |
Bernadette E Bogner, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1025 Center St, Ashland, OH 44805 Phone: 866-916-5259 Fax: 231-922-4030 | |
John P Jentes, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Hillcrest Dr, Suite 3, Ashland, OH 44805 Phone: 419-207-2502 Fax: 419-207-2394 | |
Matthew D Mcdaniel, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1025 Center St, Ashland, OH 44805 Phone: 419-289-0491 |